Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality

被引:25
|
作者
Doi, Takahito [1 ,2 ,3 ]
Langsted, Anne [1 ,2 ,3 ]
Nordestgaard, Borge G. [1 ,2 ,3 ]
机构
[1] Copenhagen Univ Hosp Herlev & Gentofte, Dept Clin Biochem, Borgmester Ib Juuls Vej 73, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Borgmester Ib Juuls Vej 73, DK-2730 Herlev, Denmark
[3] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark
基金
日本学术振兴会;
关键词
Triglycerides-rich lipoproteins; Very low-density lipoproteins; Inflammation; Cardiovascular disease; Death; CORONARY-HEART-DISEASE; TRIGLYCERIDE-RICH LIPOPROTEINS; LOW-GRADE INFLAMMATION; LOW-DENSITY; INTERLEUKIN-6; RECEPTOR; ARTERIAL INTIMA; IN-VIVO; RISK; METAANALYSIS; INDIVIDUALS;
D O I
10.1016/j.atherosclerosis.2023.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Elevated remnant cholesterol and low-grade inflammation each cause atherosclerotic cardiovascular disease (ASCVD); however, it is unknown whether joint elevation of both factors confers the highest risk. We tested the hypothesis that dual elevated remnant cholesterol and low-grade inflammation marked by elevated C-reactive protein is associated with the highest risk of myocardial infarction, ASCVD, and all-cause mortality.Methods: The Copenhagen General Population Study randomly recruited white Danish individuals aged 20-100 years in 2003-2015 and followed them for a median 9.5 years. ASCVD was cardiovascular mortality, myocardial infarction, stroke, and coronary revascularization.Results: In 103,221 individuals, we observed 2,454 (2.4%) myocardial infarctions, 5,437 (5.3%) ASCVD events, and 10,521 (10.2%) deaths. The hazard ratios increased with each of stepwise higher remnant cholesterol and stepwise higher C-reactive protein. In individuals with the highest tertile of both remnant cholesterol and C-reactive protein compared to individuals with the lowest tertile of both, the multivariable adjusted hazard ratios were 2.2 (95%CI:1.9-2.7) for myocardial infarction, 1.9 (1.7-2.2) for ASCVD, and 1.4 (1.3-1.5) for all-cause mortality. Corresponding values for only the highest tertile of remnant cholesterol were 1.6 (1.5-1.8), 1.4 (1.3-1.5), and 1.1 (1.0-1.1), and those for only the highest tertile of C-reactive protein were 1.7 (1.5-1.8), 1.6 (1.5-1.7), and 1.3 (1.3-1.4), respectively. There was no statistical evidence for interaction between elevated remnant cholesterol and elevated C-reactive protein on risk of myocardial infarction (p = 0.10), ASCVD (p = 0.40), or all-cause mortality (p = 0.74).Conclusions: Dual elevated remnant cholesterol and C-reactive protein confers the highest risk of myocardial infarction, ASCVD, and all-cause mortality, that is, compared to either of these two factors individually.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques
    Pilely, Katrine
    Fumagalli, Stefano
    Rosbjerg, Anne
    Genster, Ninette
    Skjoedt, Mikkel-Ole
    Perego, Carlo
    Ferrante, Angela M. R.
    De Simoni, Maria-Grazia
    Garred, Peter
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [32] Polymorphism C1444T of C-Reactive Protein Gene and C-Reactive Protein Concentration in Blood Serum of Healthy People and Patients With Myocardial Infarction
    Shakhnovitch, R. M.
    Sukhinina, T. S.
    Barsova, R. M.
    Sudomoina, M. A.
    Rybalkin, I. N.
    Shreider, E. V.
    Vlasik, T. N.
    Favorova, O. O.
    Ruda, M. Ya.
    KARDIOLOGIYA, 2010, 50 (08) : 4 - 12
  • [33] Impact of C-reactive protein on long-term mortality in acute myocardial infarction patients with diabetes and those without
    Xia, Ming
    Zhang, Chi
    Gu, Jian
    Chen, Jing
    Wang, Lin-Chi
    Lu, Yan
    Huang, Chun-Yan
    He, Yong-Ming
    Yang, Xiang-Jun
    CLINICA CHIMICA ACTA, 2018, 480 : 220 - 224
  • [34] Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein
    Jeong, Hae Chang
    Ahn, Youngkeun
    Hong, Young Joon
    Kim, Ju Han
    Jeong, Myung Ho
    Kim, Young Jo
    Chae, Shung Chull
    Cho, Myeong Chan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (05) : 1848 - 1853
  • [35] Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction
    Habersberger, Jonathon
    Strang, Frederik
    Scheichl, Amelie
    Htun, Nay
    Bassler, Nicole
    Merivirta, Ruusu-Maaria
    Diehl, Philipp
    Krippner, Guy
    Meikle, Peter
    Eisenhardt, Steffen U.
    Meredith, Ian
    Peter, Karlheinz
    CARDIOVASCULAR RESEARCH, 2012, 96 (01) : 64 - 72
  • [36] Prognostic Role of High Sensitivity C-Reactive Protein in Patients With Acute Myocardial Infarction
    Zhang, Xiaoyuan
    Wang, Shanjie
    Fang, Shaohong
    Yu, Bo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [37] Possible mechanisms of C-reactive protein mediated acute myocardial infarction
    Fordjour, Patrick Asare
    Wang, Yadong
    Shi, Yang
    Agyemang, Kojo
    Akinyi, Mary
    Zhang, Qiang
    Fan, Guanwei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 760 : 72 - 80
  • [38] Periodontitis Predicts Elevated C-reactive Protein Levels in Chronic Kidney Disease
    Ioannidou, E.
    Swede, H.
    Dongari-Bagtzoglou, A.
    JOURNAL OF DENTAL RESEARCH, 2011, 90 (12) : 1411 - 1415
  • [39] C-reactive protein and the risk of cardiovascular morbidity and mortality
    Poredos, Pavel
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2017, 46 (02) : 77 - 78
  • [40] Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease
    Li, Xi
    Li, Zhi-Fan
    Wu, Na-Qiong
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2025, 26 (02)